IBEX develops a product suite to improve clinical decision-making and to streamline pathology laboratory workflows.
Ibex Medical Analytics has raised €42M across 2 funding rounds from 3 investors, most recently a Series B round in Mar 2021. Based in Tel Aviv, Israel; founded 2016; active in Software and Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2021-03-09 | Series B | €32M | 83North,Octopus Ventures | View deal → |
| 2019-01-01 | Series A | €9.6M | aMoon Fund | View deal → |
